Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 9,711 | 12,888 | 12,598 | 8,987 | 7,182 |
| Operating Income | -9,711 | -12,888 | -12,598 | -8,987 | -7,182 |
| Other Income | 1,874 | 1,294 | 623 | 493 | 20 |
| Pre-tax Income | -7,837 | -11,594 | -11,975 | -8,494 | -7,162 |
| Net Income Continuous | -7,837 | -11,594 | -11,975 | -8,494 | -7,162 |
| Net Income | $-7,837 | $-11,594 | $-11,975 | $-8,494 | $-7,162 |
| EPS Basic Total Ops | -0.06 | -0.10 | -0.12 | -0.08 | -0.07 |
| EPS Basic Continuous Ops | -0.06 | -0.10 | -0.12 | -0.08 | -0.07 |
| EPS Diluted Total Ops | -0.06 | -0.10 | -0.12 | -0.08 | -0.07 |
| EPS Diluted Continuous Ops | -0.06 | -0.10 | -0.12 | -0.08 | -0.07 |
| EBITDA(a) | $-9,823 | $-13,015 | $-12,411 | $-8,379 | $-6,747 |